OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - ELI LILLY & CO | Market Closed - Bid/Ask 03:36:22 2024-05-16 pm EDT | Pre-market 02:11:44 am | |||
| 17.65 EUR | +6.20% |
|
17.76 | +0.62% |
| Current month | +1.38% | ||
| 1 month | -13.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-05-16 | 17.65 | +6.20% |
| 24-05-15 | 16.62 | -11.31% |
| 24-05-14 | 18.74 | -2.75% |
| 24-05-13 | 19.27 | +1.05% |
| 24-05-10 | 19.07 | +7.01% |
Real-time Boerse Frankfurt Warrants
Last update May 16, 2024 at 03:36 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | SU7ZV8 |
| ISIN | DE000SU7ZV85 |
| Date issued | 2024-02-07 |
| Strike | 965 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 23.13 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 23.79 € |
|---|---|
| Lowest since issue | 15.01 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
771.1
USD
Average target price
850.4
USD
Spread / Average Target
+10.28%
- Stock Market
- Certificates
- Certificat
